INTRODUCTIONA 58-year-old African-American male with a past medical history of hypertension, diabetes mellitus, tobacco use, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and hyperlipidemia presented with a two-year history of asymptomatic light spots…

The National Capital Consortium (NCC) Dermatology Residency is one of the military's three dermatology training programs and is located at the recently opened Walter Reed National Military Medical Center (WRNMMC)…

INTRODUCTIONDrug-associated adverse events (AEs) are frequently observed in patients who receive interferon-α therapy; included among these side effects are cutaneous manifestations, which can be generalized or localized to the injection…

Disclosures"The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Army, Department of…

INTRODUCTIONElephantiasis nostras verrucosa is an uncommon disease characterized by cutaneous changes consisting of hyperkeratotic, verrucous, and papillomatous lesions after chronic secondary filarial and nonfilarial lymphedema. The other names reported in…

INTRODUCTIONIn October 2005, a 45-year-old woman, non-smoker, who was engaged in a demanding career as a law counselor for an investment bank, consulted a physician due to the eruption of…

INTRODUCTIONPsoriasis is a chronic skin condition that affects 1% to 3% of the general population. In patients with human immunodeficiency syndrome (HIV), one study reported the prevalence of psoriasis as…

INTRODUCTIONA 22-year-old male presented to his physician with a two- week history of fevers, night sweats, and a new tender erythematous plaque on the left buttock (Figure 1). He was…

IntroductionThe MelaFind computer-based imaging system was approved by the FDA and the European Union in Fall 2011 for the evaluation of concerning pigmented lesions after selection by dermatologists. It is…

FDA Requires Follow-Up on TNF blocker Malignancy CasesThe FDA has announced that it is requiring that manufacturers of tumor necrosis factor (TNF) blockers perform enhanced safety surveillance in children, teenagers,…

CUTANEOUS LUPUS ERYTHEMATOSUSA Randomized, Subject and Investigator-Blinded (Sponsor-Open), Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Multiple Ascending Doses of PD- 0360324 in Subjects with Active Cutaneous…